Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease
|
October 29, 2020
Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
Robert Sandhaus, Charlie Strange, Glenda Stone, et al.
Headache
|
November 15, 2011
Examining the interrelationship of migraine onset, duration, and time to treatment
Stephen H Landy, M Chris Runken, Christopher F Bell, et al.
Journal of Occupational and Environmental Medicine
|
December 29, 2010
Assessing the impact of migraine onset on work productivity
Stephen H Landy, M Chris Runken, Christopher F Bell, et al.
Journal of Medical Economics
|
April 24, 2018
Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States
Ellis J Neufeld, Robert F Sidonio, Ken O'Day, et al.
Current Alzheimer Research
|
September 25, 2024
Post-Hoc Assessment of Cognitive Efficacy in Alzheimer's Disease Using a Latent Growth Mixture Model in AMBAR, a Phase 2B Randomized Controlled Trial
Nicolai D Ayasse, Walter F Stewart, Richard B Lipton, et al.
Journal of Diabetes and Its Complications
|
July 9, 2016
The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy
Vera Bril, Christopher M Blanchette, Joshua M Noone, et al.
Headache
|
June 19, 2013
A cross-sectional survey to assess the migraineur's medication decision-making beliefs: determining when a migraine is triptan-worthy
Stephen H Landy, Ira M Turner, M Chris Runken, et al.
Applied Health Economics and Health Policy
|
October 9, 2014
Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA
M Chris Runken, Bridgett Goodwin, Manan Shah, et al.
Current Medical Research and Opinion
|
March 3, 2009
Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage
Miriam G Cisternas, Aimee J Foreman, Thomas S Marshall, et al.
Headache
|
September 3, 2013
Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study
Richard B Lipton, Daniel Serrano, Robert A Nicholson, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
International Journal of Chronic Obstructive Pulmonary Disease
|
October 29, 2020
Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
Robert Sandhaus, Charlie Strange, Glenda Stone, et al.
Headache
|
November 15, 2011
Examining the interrelationship of migraine onset, duration, and time to treatment
Stephen H Landy, M Chris Runken, Christopher F Bell, et al.
Journal of Occupational and Environmental Medicine
|
December 29, 2010
Assessing the impact of migraine onset on work productivity
Stephen H Landy, M Chris Runken, Christopher F Bell, et al.
Journal of Medical Economics
|
April 24, 2018
Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States
Ellis J Neufeld, Robert F Sidonio, Ken O'Day, et al.
Current Alzheimer Research
|
September 25, 2024
Post-Hoc Assessment of Cognitive Efficacy in Alzheimer's Disease Using a Latent Growth Mixture Model in AMBAR, a Phase 2B Randomized Controlled Trial
Nicolai D Ayasse, Walter F Stewart, Richard B Lipton, et al.
Journal of Diabetes and Its Complications
|
July 9, 2016
The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy
Vera Bril, Christopher M Blanchette, Joshua M Noone, et al.
Headache
|
June 19, 2013
A cross-sectional survey to assess the migraineur's medication decision-making beliefs: determining when a migraine is triptan-worthy
Stephen H Landy, Ira M Turner, M Chris Runken, et al.
Applied Health Economics and Health Policy
|
October 9, 2014
Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA
M Chris Runken, Bridgett Goodwin, Manan Shah, et al.
Current Medical Research and Opinion
|
March 3, 2009
Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage
Miriam G Cisternas, Aimee J Foreman, Thomas S Marshall, et al.
Headache
|
September 3, 2013
Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study
Richard B Lipton, Daniel Serrano, Robert A Nicholson, et al.
Page
of 4